Format
Sort by
Items per page

Send to

Choose Destination

Best matches for (alopecia OR baldness OR "hair loss") AND (tnf-alpha OR tgf-beta):

Search results

Items: 1 to 20 of 269

1.

Lichen planopilaris induced by infliximab: A case report.

McPhie ML, Wang A, Molin S, Herzinger T.

SAGE Open Med Case Rep. 2020 Jan 28;8:2050313X20901967. doi: 10.1177/2050313X20901967. eCollection 2020.

2.

Resolution of post-adalimumab vitiligo with secukinumab in a patient with psoriasis vulgaris.

Palazzo G.

Oxf Med Case Reports. 2020 Jan 31;2020(1):omz134. doi: 10.1093/omcr/omz134. eCollection 2020 Jan.

3.

Therapy-Recalcitrant Folliculitis Decalvans Controlled Successfully with Adalimumab.

Alhameedy MM, Alsantali AM.

Int J Trichology. 2019 Nov-Dec;11(6):241-243. doi: 10.4103/ijt.ijt_92_19.

4.

Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation.

Skupsky J, Sabui S, Hwang M, Nakasaki M, Cahalan MD, Said HM.

Cell Mol Gastroenterol Hepatol. 2019 Nov 29;9(4):557-567. doi: 10.1016/j.jcmgh.2019.11.011. [Epub ahead of print]

5.

Alopecia Universalis in a Case of Rheumatoid Arthritis after Treatment with Etanercept.

Kandpal R.

Int J Trichology. 2019 Jul-Aug;11(4):173-176. doi: 10.4103/ijt.ijt_22_19.

6.

In silico analysis of gene expression data from bald frontal and haired occipital scalp to identify candidate genes in male androgenetic alopecia.

Premanand A, Rajkumari BR.

Arch Dermatol Res. 2019 Dec;311(10):815-824. doi: 10.1007/s00403-019-01973-2. Epub 2019 Sep 11.

PMID:
31511972
7.

Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Speeckaert R, Lambert J, van Geel N.

Front Immunol. 2019 Aug 8;10:1918. doi: 10.3389/fimmu.2019.01918. eCollection 2019. Review.

8.

Adalimumab-induced scalp psoriasis with severe alopecia.

Özkur E, Altunay İK, Leblebici C, Topkarcı Z, Erdem Y.

Dermatol Ther. 2019 Sep;32(5):e13033. doi: 10.1111/dth.13033. Epub 2019 Aug 22.

PMID:
31350777
9.

Conditional Upregulation of IFN-α Alone Is Sufficient to Induce Systemic Lupus Erythematosus.

Akiyama C, Tsumiyama K, Uchimura C, Honda E, Miyazaki Y, Sakurai K, Miura Y, Hashiramoto A, Felsher DW, Shiozawa S.

J Immunol. 2019 Aug 15;203(4):835-843. doi: 10.4049/jimmunol.1801617. Epub 2019 Jul 19.

PMID:
31324723
10.

Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.

Takahashi T, Yamasaki K, Terui H, Omori R, Tsuchiyama K, Fujimura T, Aiba S.

J Dermatol. 2019 Sep;46(9):802-807. doi: 10.1111/1346-8138.14998. Epub 2019 Jul 4. Review.

PMID:
31271451
11.

Tumor necrosis factor-α inhibitor-induced psoriasis in juvenile idiopathic arthritis patients.

Groth D, Perez M, Treat JR, Castelo-Soccio L, Nativ S, Weiss PF, Lapidus S, Perman MJ.

Pediatr Dermatol. 2019 Sep;36(5):613-617. doi: 10.1111/pde.13859. Epub 2019 Jun 25.

PMID:
31240749
12.

The Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus.

Raymond WD, Eilertsen GØ, Shanmugakumar S, Nossent JC.

J Clin Med. 2019 Jun 15;8(6). pii: E857. doi: 10.3390/jcm8060857.

13.

Dental derived stem cell conditioned media for hair growth stimulation.

Gunawardena TNA, Masoudian Z, Rahman MT, Ramasamy TS, Ramanathan A, Abu Kasim NH.

PLoS One. 2019 May 1;14(5):e0216003. doi: 10.1371/journal.pone.0216003. eCollection 2019.

14.

Novel therapeutic approaches in utilizing platelet lysate in regenerative medicine: Are we ready for clinical use?

Zamani M, Yaghoubi Y, Movassaghpour A, Shakouri K, Mehdizadeh A, Pishgahi A, Yousefi M.

J Cell Physiol. 2019 Aug;234(10):17172-17186. doi: 10.1002/jcp.28496. Epub 2019 Mar 25. Review.

PMID:
30912141
15.

Ustekinumab for skin reactions associated with anti-tumor necrosis factor-α agents in patients with inflammatory bowel diseases: A single-center retrospective study.

Ezzedine K, Visseaux L, Cadiot G, Brixi H, Bernard P, Reguiai Z.

J Dermatol. 2019 Apr;46(4):322-327. doi: 10.1111/1346-8138.14816. Epub 2019 Feb 28.

PMID:
30816581
16.

Premature aging and cancer development in transgenic mice lacking functional CYLD.

Alameda JP, Ramírez Á, García-Fernández RA, Navarro M, Page A, Segovia JC, Sanchez R, Suárez-Cabrera C, Paramio JM, Bravo A, Fernández-Aceñero MJ, Casanova ML.

Aging (Albany NY). 2019 Jan 10;11(1):127-159. doi: 10.18632/aging.101732.

17.

[What's new in dermatological treatment?]

Descamps V.

Ann Dermatol Venereol. 2018 Dec;145 Suppl 7:VIIS47-VIIS55. doi: 10.1016/S0151-9638(18)31289-4. Review. French.

PMID:
30583757
18.

Regulatory T Cells and Their Association with Serum Markers and Symptoms in Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Kailashiya V, Singh U, Rana R, Singh NK, Dash D, Kailashiya J.

Immunol Invest. 2019 Jan;48(1):64-78. doi: 10.1080/08820139.2018.1527852. Epub 2018 Oct 16.

PMID:
30325682
19.

Alteration of serum and tissue tumor necrosis factor alpha levels: A possible mechanism of action of oral pulse steroids in the treatment of alopecia areata.

Abdel Halim D, Abu Zeid OM, Rashed L, Saleh MA.

J Cosmet Dermatol. 2019 Aug;18(4):1128-1132. doi: 10.1111/jocd.12795. Epub 2018 Oct 7.

PMID:
30294905
20.

Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition.

Diviccaro S, Giatti S, Borgo F, Barcella M, Borghi E, Trejo JL, Garcia-Segura LM, Melcangi RC.

Psychoneuroendocrinology. 2019 Jan;99:206-215. doi: 10.1016/j.psyneuen.2018.09.021. Epub 2018 Sep 18.

PMID:
30265917

Supplemental Content

Loading ...
Support Center